Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Blood
Reexamination Certificate
2006-05-16
2006-05-16
Li, Q. Janice (Department: 1633)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Blood
C424S093700, C435S002000, C435S325000
Reexamination Certificate
active
07045148
ABSTRACT:
A method of collecting embryonic-like stem cells from a placenta which has been treated to remove residual cord blood by perfusing the drained placenta with an anticoagulant solution to flush out residual cells, collecting the residual cells and perfusion liquid from the drained placenta, and separating the embryonic-like cells from the residual cells and perfusion liquid. Exogenous cells can be propagated in the placental bioreactor and bioactive molecules collected therefrom.
REFERENCES:
patent: 3862002 (1975-01-01), Sanders
patent: 4829000 (1989-05-01), Kleinman et al.
patent: 5004681 (1991-04-01), Boyse et al.
patent: 5192553 (1993-03-01), Boyse et al.
patent: 5372581 (1994-12-01), Anderson
patent: 5415665 (1995-05-01), Hessel et al.
patent: 5635387 (1997-06-01), Fei et al.
patent: 5665557 (1997-09-01), Murray et al.
patent: 5670351 (1997-09-01), Emerson et al.
patent: 5827735 (1998-10-01), Young et al.
patent: 5866414 (1999-02-01), Badylak et al.
patent: 5874301 (1999-02-01), Keller et al.
patent: 5879318 (1999-03-01), Van Der Heiden et al.
patent: 5905041 (1999-05-01), Beug et al.
patent: 5914108 (1999-06-01), Tsukamoto et al.
patent: 5914268 (1999-06-01), Keller et al.
patent: 5916202 (1999-06-01), Haswqell
patent: 5919176 (1999-07-01), Kuypers et al.
patent: 5928214 (1999-07-01), Rubinstein et al.
patent: 5993429 (1999-11-01), Kuypers et al.
patent: 6030836 (2000-02-01), Thiede
patent: 6059968 (2000-05-01), Wolf, Jr.
patent: 6110739 (2000-08-01), Keller et al.
patent: 6179819 (2001-01-01), Haswel
patent: 6190368 (2001-02-01), Kuypers et al.
patent: 6255112 (2001-07-01), Thiede et al.
patent: 6326019 (2001-12-01), Tseng
patent: 6461645 (2002-10-01), Boyse et al.
patent: 2002/0132343 (2002-09-01), Lum
patent: WO 00/17325 (2000-03-01), None
patent: WO 00/73421 (2000-12-01), None
Placenta, Encyclopaedia Britannia, 2003.
Ma et al, Tissue Engineering 1999;5:91-102.
Contractor et al, Cell Tis Res 1984;237:609-17.
Muhlemann et al, palcenta 1995 ;16 :367-73.
Belvedere et al , Stem Cells Jul. 2000;18:245-51.
Addison et al, J Steroid Biochem Molec Biol 1991;83-90.
Bersinger et al, Reprod Fertil Dev 1992;4:585-8.
Placenta. Mesh, Pubmed, 2003.
Minguell et al, Exp Biol Med 2001;226:507-20.
Cord Blood Stem Cell, Mesh Term database 2003.
Totipotent stem cells, Stem Cells Information Center On-line, 2004.
Papaioannou et al, Stem Cells Handbook 2004;19-31.
CD34, Medline Mesh database, 2004.
Totipotent stem cells, Medline Mesh database, 2004.
Tissue culture: Merriam-Webster's Online Dictionary 2004.
Expansion of human cord blood CD34+CD38- cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function (Blood, vol. 95, No. 1, p. 102-110, Jan. 2000) C. Dorrell.
Ex Vivo Expansion of Hematopoietic Precursors, Progenitors, and Stem Cells: The Next Generation of Cellular Therapeutics (Blood, vol. 87, No. 8, p. 3082-3088 (Apr. 1996) ) Stephen G. Emerson.
Ex Vivo Expansionof Hematopoietic Stem and Progenitor Cells: Are We There Yet? (The Journal of Hematotherapy, vol. 8, p. 93-102 (1999) ) Srour, et al.
Myllynen, In Search of Models for Hepatic and Placental Pharmacokinetics, dissertation, University of Oulu (2003).
van Bekkum, “The Pluripotent Hemopoietic Stem Cell: Its Identification and Applications,”Verh. Disch. Ges. Pathol.74:19-24 (1990).
Caplan, “The Mesengenic Process,”Clin. Plast. Surg.21(3):429-435 (1994)).
Contractor et al., A comparison of the effects of different perfusion regimes on the structure of the isolated human placental lobule. Cell Tissue Res. 237:609-617 (1984).
Hatzopoulos et al., “Isolation and characterization of endothelial progenitor cells from mouse embryos”, Development 125:1457-1468 (1998).
Moore et al., “A simple perfusion technique for isolation of maternal intervillous blood mononuclear cells from human placentae”, J. Immunol. Methods 209:93-104 (1997).
Shamblott et al., “Derivation of pluripotent stem cells from cultured human primordial germ cells”, Proc. Natl. Acad. Sci. U S A. 95:13726-13731 (1998). Erratum in: Proc. Natl. Acad. Sci. U S A 96:1162 (1999).
Thompson et al., “Embryonic stem cell lines derived from human blastocysts”, Science 282:1145-1147 (1998); Erratum in: Science 282:1827 (1998).
Turner et al., “A modified harvest technique for cord blood hematopoietic stem cells”, Bone Marrow Transplant. 10:89-91 (1992).
Wang et al., “Enhanced recovery of hematopoietic progenitor and stem cells from cultivated postpartum human placenta”, Blood 98(11/1):183a, abstract No. 769 (2001).
Ye et al., “Recovery of placental-derived adherent cells with mesenchymal stem cell characteristics”, Blood 98(11/1):147b, abstract No. 4260 (2001).
Anthrogenesis Corporation
Jones Day
Li Q. Janice
LandOfFree
Method of collecting placental stem cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of collecting placental stem cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of collecting placental stem cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3642710